Media & Press Releases

EpicentRx, Inc. in an Expansive Growth Phase

EpicentRx, Inc. in an Expansive Growth Phase

Company secures 10M US dollar growth capital term loan from Silicon Valley Bank (SVB) to accelerate development of immunotherapies for cancer AdAPT-001, a TGF-beta trap expressing oncolytic virus, designed to activate the immune system and improve checkpoint...

read more